These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19614635)

  • 1. Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes--cardiac safety of gadobutrol.
    Malik M; Hnatkova K; Schmidt A; Smetana P
    Ann Noninvasive Electrocardiol; 2009 Jul; 14(3):242-50. PubMed ID: 19614635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of QT/RR hysteresis correction in studies of drug-induced QTc interval changes.
    Malik M; Garnett C; Hnatkova K; Johannesen L; Vicente J; Stockbridge N
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):491-503. PubMed ID: 29651591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects.
    Davis JD; Hackman F; Layton G; Higgins T; Sudworth D; Weissgerber G
    Br J Clin Pharmacol; 2008 Apr; 65 Suppl 1(Suppl 1):68-75. PubMed ID: 18333868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization.
    Kleiman RB; Darpo B; Thorn M; Stoehr T; Schippers F
    Br J Clin Pharmacol; 2020 Aug; 86(8):1600-1609. PubMed ID: 32144789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
    de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P
    Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subject-specific profiles of QT/RR hysteresis.
    Malik M; Hnatkova K; Novotny T; Schmidt G
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2356-63. PubMed ID: 18849333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
    Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
    Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers.
    He YL; Zhang Y; Serra D; Wang Y; Ligueros-Saylan M; Dole WP
    Curr Med Res Opin; 2011 Jul; 27(7):1453-63. PubMed ID: 21609207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
    Malik M
    J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the precision of QT measurements.
    Darpo B; Fossa AA; Couderc JP; Zhou M; Schreyer A; Ticktin M; Zapesochny A
    Cardiol J; 2011; 18(4):401-10. PubMed ID: 21769821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.
    Morganroth J; Wang Y; Thorn M; Kumagai Y; Harris S; Stockbridge N; Kleiman R; Shah R
    Br J Clin Pharmacol; 2015 Sep; 80(3):446-59. PubMed ID: 26011050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of mericitabine at projected therapeutic and supratherapeutic doses on cardiac repolarization in healthy subjects: A thorough QT/QTc study.
    Chen YC; Haznedar J; Kulkarni R; Vistuer C; Washington C; Liu M; Smith P
    Clin Pharmacol Drug Dev; 2014 May; 3(3):179-86. PubMed ID: 27128607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of olanzapine and samidorphan has no clinically relevant effects on ECG parameters, including the QTc interval: Results from a phase 1 QT/QTc study.
    Sun L; Yagoda S; Xue H; Brown R; Nangia N; McDonnell D; Rege B; von Moltke L; Darpo B
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jun; 100():109881. PubMed ID: 32004636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal Correction for QT/RR Hysteresis.
    Malik M; Johannesen L; Hnatkova K; Stockbridge N
    Drug Saf; 2016 Jun; 39(6):577-88. PubMed ID: 26968541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
    Kubitza D; Mueck W; Becka M
    Drug Saf; 2008; 31(1):67-77. PubMed ID: 18095747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis.
    Timmers M; Sinha V; Darpo B; Smith B; Brown R; Xue H; Ferber G; Streffer J; Russu A; Tritsmans L; Solanki B; Bogert J; Van Nueten L; Salvadore G; Nandy P
    J Clin Pharmacol; 2018 Jul; 58(7):952-964. PubMed ID: 29505101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056).
    Ufer M; Sagkriotis A; Salunke A; Ganesan S; Tisserant A; Dodman A; Voltz E; Woessner R; Jordaan P; Legangneux E
    Clin Ther; 2016 Dec; 38(12):2589-2597. PubMed ID: 27823869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.